menu ☰
menu ˟

Enrollment complete in Allegro's phase 2b trial of Luminate

03 Oct 2016
The last patient has been enrolled in Allegro Ophthalmics’ phase 2b trial of Luminate for inducing posterior vitreous detachment in patients with nonproliferative diabetic retinopathy, according to a company press release.Intravitreal injections of...

Click here to view the full article which appeared in Opthalmology

IPH Logo